[1]
“In silico characterization of missense mutations in PI3K/AKT/mTOR signaling genes in breast cancer and their role in therapeutic resistance”, Ann Med Res , vol. 32, no. 12, pp. 541–551, Dec. 2025, Accessed: Dec. 28, 2025. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/4890